A U.K. marketing watchdog has sided with Roche over Bayer after a spat between the companies boiled over, ruling that prelicense promotion of the German drugmaker’s eye med discredited the industry.
CMS innovation center to expand team focused on drug prices
To help with new pilot models aimed at lowering drug costs across Medicaid and Medicare, CMS’ innovation center is ramping up staff. “We are on


